The pros and cons of lamivudine vs. entecavir in decompensated or severe acute exacerbation of chronic hepatitis B

被引：6
|
作者：
Shouval, Daniel [1 ]
机构：
[1] Hadassah Hebrew Univ Hosp, Liver Unit, IL-91120 Jerusalem, Israel
来源：
JOURNAL OF HEPATOLOGY | 2014年 / 60卷 / 06期
关键词：
LACTIC-ACIDOSIS; NUCLEOSIDE; CIRRHOSIS; ANALOGS;
D O I：
10.1016/j.jhep.2014.03.004
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1108 / 1109
页数：2
相关论文
共 50 条
  • [1] Entecavir vs. lamivudine in chronic hepatitis B patients with severe acute exacerbation and hepatic decompensation
    Chen, Chien-Hung
    Lin, Chih-Lang
    Hu, Tsung-Hui
    Hung, Chao-Hung
    Tseng, Po-Lin
    Wang, Jing-Houng
    Chang, Juan-Yu
    Lu, Sheng-Nan
    Chien, Rong-Nan
    Lee, Chuan-Mo
    JOURNAL OF HEPATOLOGY, 2014, 60 (06) : 1127 - 1134
  • [2] Efficacy of Lamivudine or Entecavir on Acute Exacerbation of Chronic Hepatitis B
    Kanda, Tatsuo
    Shinozaki, Masami
    Kamezaki, Hidehiro
    Wu, Shuang
    Nakamoto, Shingo
    Arai, Makoto
    Fujiwara, Keiichi
    Goto, Nobuaki
    Imazeki, Fumio
    Yokosuka, Osamu
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2012, 9 (01): : 27 - 32
  • [3] Tenofovir, entecavir, and lamivudine in patients with severe acute exacerbation and hepatic decompensation of chronic hepatitis B
    Park, Jung Gil
    Lee, Yu Rim
    Park, Soo Young
    Lee, Heon Ju
    Tak, Won Young
    Kweon, Young Oh
    Jang, Se Young
    Chun, Jae Min
    Han, Young Seok
    Hur, Keun
    Lee, Hye Won
    Kang, Min Kyu
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : 163 - 167
  • [4] Entecavir vs. tenofovir disoproxil fumarate in the treatment of chronic hepatitis B patients with severe acute exacerbation
    Lin, Chih-Yang
    Sun, Wei-Chih
    Lu, Chia-Ming
    Chen, Wen-Chi
    Tsay, Feng-Woei
    Tsai, Tzun-Jiun
    Kuo, Feng-Yu
    Tsai, Wei-Lun
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 36 (09) : 1113 - 1118
  • [5] Entecavir and lamivudine therapy for severe acute chronic hepatitis B
    Liu, Changhong
    Ye, Jing
    Jia, Hongyu
    Zhang, Meijuan
    Han, Hongfeng
    Chen, Fengzhe
    Chen, Congkang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 5 (02) : 545 - 548
  • [6] Early Entecavir Treatment for Chronic Hepatitis B with Severe Acute Exacerbation
    Tsai, Wei-Lun
    Chiang, Hung
    Chan, Hoi-Hung
    Lin, Huey-Shyan
    Lai, Kwok-Hung
    Cheng, Jin-Shiung
    Chen, Wen-Chi
    Tsay, Feng-Woei
    Wang, Huay-Min
    Tsai, Tzung-Jiun
    Yu, Hsien-Chung
    Hsu, Ping-I
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (04) : 1918 - 1921
  • [7] Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B
    Wong, Vincent Wai-Sun
    Wong, Grace Lai-Hung
    Yiu, Karen Kar-Lum
    Chim, Angel Mei-Ling
    Chu, Shirley Ho-Ting
    Chan, Hoi-Yun
    Sung, Joseph Jao-Yiu
    Chan, Henry Lik-Yuen
    JOURNAL OF HEPATOLOGY, 2011, 54 (02) : 236 - 242
  • [8] Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B
    Tsubota, A
    Arase, Y
    Suzuki, Y
    Suzuki, F
    Sezaki, H
    Hosaka, T
    Akuta, N
    Someya, T
    Kobayashi, M
    Saitoh, S
    Ikeda, K
    Kumada, H
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 20 (03) : 426 - 432
  • [9] Treatment with lamivudine and entecavir in severe acute hepatitis B
    Streinu-Cercel, A.
    Sandulescu, O.
    Stefan, M.
    Streinu-Cercel, A.
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2016, 34 (02) : 166 - 172
  • [10] Tenofovir versus entecavir in the treatment of chronic hepatitis B with severe acute exacerbation
    Hung, Chao-Hung
    Chen, Chien-Hung
    Lu, Sheng-Nan
    Hu, Tsung-Hui
    Wang, Jing-Houng
    Lee, Chuan-Mo
    HEPATOLOGY, 2014, 60 : 1118A - 1118A
12345